Fexofenadine

3 trials 2 recruiting RRespiratory

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

2 Recruiting

1 Completed trials

3 Sponsors

12 Countries

Phase III

Phase I (FiH)

Phase III: 2 Phase I (FiH): 1

Indications tested

IgA nephropathy 1 Pruritus 1

Sponsors using this IMP

Biogen Idec Research Limited 1 Moderna Inc. 1 Sanofi-Aventis Recherche & Developpement 1

All trials

3 total

A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN) ( PREVAIL ) Recruiting

2024-519345-30-00 Phase III 11 countries Biogen Idec Research Limited
Efficacy and safety of subcutaneous dupilumab for the treatment of adult participants with chronic pruritus of unknown origin (CPUO) Recruiting

2023-508879-36-00 Phase III 6 countries Sanofi-Aventis Recherche & Developpement
A dose-finding study to evaluate mRNA-3210 in participants with phenylketonuria Ended

2023-506963-32-00 Phase I (FiH) 3 countries Moderna Therapeutics Inc.

Showing 1–3 of 3 trials

← All drugs A–Z